#None #Class Action #Securities Fraud #uniQure

Levi & Korsinsky Issues Reminder to UniQure Shareholders

Levi & Korsinsky, LLP has recently alerted investors of uniQure N.V. (NASDAQ: QURE) regarding a significant class action securities lawsuit. This announcement comes as the firm seeks to recover losses for shareholders affected by alleged fraudulent activities associated with uniQure's operations. The defined class period for the lawsuit is from September 24, 2025, to October 31, 2025, targeting those who suffered losses during these dates. The plaintiffs claim that false statements were made concerning the company’s pivotal study design and its FDA approval status, suggesting that the results of the pivotal study were overstated.

Details of the Case

According to the filed complaint, several allegations have surfaced indicating that the defendants withheld essential information regarding the study's approval and the company's operational forecasts. Specific points of contention include:

1. Alleged misrepresentations concerning the approval status of the pivotal study by the FDA, which was not completely sanctioned before it was presented to investors.
2. The downplay of the potential delays the company might face in their Biologics License Application (BLA) submission, even when claiming successful initial results from their study.
3. As a result of the above issues, it is asserted that statements made about the company’s potential and business prospects lacked a reasonable basis and misled investors.

Key Deadlines for Investors

Investors who believe they’ve incurred losses in uniQure have until April 13, 2026, to submit requests for the Court to appoint them as the lead plaintiff in this case. Importantly, participation in recovery efforts does not necessitate serving as a lead plaintiff. This is an essential opportunity for affected shareholders to come forward and seek justice for their losses.

No Financial Obligation

Levi & Korsinsky emphasizes that for shareholders who qualify as class members, the process is designed to be without out-of-pocket expenses. It is stated clearly that there are no fees or obligations for participation, making it accessible for all affected parties.

Experience of Levi & Korsinsky

The legal team at Levi & Korsinsky brings two decades of experience and a solid track record in securities litigation. They have successfully secured hundreds of millions of dollars for shareholders in similar cases, showcasing their capability in handling complex legal matters related to investor rights. Their team's expertise is highlighted by their continued recognition as one of the nation's leading firms in securities litigation, as recognized in ISS Securities Class Action Services' annual report.

How to Get Involved

Shareholders can easily get in touch with Levi & Korsinsky for more information or to participate in the lawsuit. The firm encourages direct communication via email at [email protected] or by calling Joseph E. Levi, Esq. at (212) 363-7500. Interested investors can also fill out a form available on their website dedicated to the uniQure lawsuit to facilitate further inquiries and actions.

For additional information, you can visit Levi & Korsinsky’s official website or keep an eye on updates regarding this ongoing case. This notice serves as a critical reminder for shareholders to take timely action regarding their rights and potential compensations due to the alleged misconduct by uniQure's management.